Concepedia

Subbulaxmi Trikudanathan

ST

Statistics

Publications

14

Citations

4.3K

H-Index

14

Active since

2006

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

University of Washington

Joslin Diabetes Center

Baker Heart and Diabetes Institute

Subbulaxmi Trikudanathan is an author at Harvard University specializing in medicine, diabetes, and metabolic syndrome.

ORCID

Top concepts

Publications per year

2006–2022

14

Publications

14

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Sue A. Brown, Gregory P. Forlenza, Bruce W. Bode et al. · Diabetes Care · 2021 · 257 citations · Full text

Mechanisms of PDL1-mediated regulation of autoimmune diabetes

Indira Guleria, Melanie Gubbels Bupp, Shirine Dada et al. · Clinical Immunology · 2007 · 126 citations

, , +6

Association of Female Reproductive Factors with Body Composition: The Framingham Heart Study

Subbulaxmi Trikudanathan, Alison Pedley, Joseph M. Massaro et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 96 citations · Full text

1–5 of 14